Your browser doesn't support javascript.
loading
Anatomic extent of lymph node metastases as an independent prognosticator in node-positive major salivary gland carcinoma: A study of the US SEER database and a Chinese multicenter cohort.
Shi, Xiao; Liu, Xue-Kui; An, Chang-Ming; Wei, Wen-Jun; Tao, Yungan; Ji, Yuan; Zhang, Yan; Han, Wei; Xue, Jin-Cai; Huang, Nai-Si; Ma, Ben; Zhang, Chen-Ping; Yang, Xi; Wang, Ke-Jing; Liu, Qin-Jiang; Liu, Yang; Wang, Yu; Lei, Bo-Wen; Yu, Peng-Cheng; Hu, Jia-Qian; Lu, Zhong-Wu; Hu, Wei-Ping; Tian, You-Xin; Wang, Yu-Long; Ji, Qing-Hai.
Affiliation
  • Shi X; Department of Head and Neck Surgery, Fudan University Shanghai Cancer Center, Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China.
  • Liu XK; State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Department of Head and Neck Surgery, Sun Yat-sen University Cancer Center, Guangzhou, China.
  • An CM; Department of Head and Neck Surgery, National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
  • Wei WJ; Department of Head and Neck Surgery, Fudan University Shanghai Cancer Center, Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China.
  • Tao Y; Department of Radiation Oncology, Gustave Roussy Cancer Campus, Villejuif, France.
  • Ji Y; Center for Clinical and Research Informatics, Program of Computational Genomics & Medicine, NorthShore University HealthSystem, Department of Public Health Sciences, University of Chicago, Chicago, USA.
  • Zhang Y; Department of Head and Neck Surgery, Zhejiang Cancer Hospital, Hangzhou, China.
  • Han W; Department of Oral and Maxillofacial Surgery, Nanjing Stomatological Hospital, Medical School of Nanjing University, Nanjing, China.
  • Xue JC; Department of Head and Neck Surgery, Gansu Province Cancer Hospital, Lanzhou, China.
  • Huang NS; Department of Head and Neck Surgery, Fudan University Shanghai Cancer Center, Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China.
  • Ma B; Department of Head and Neck Surgery, Fudan University Shanghai Cancer Center, Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China.
  • Zhang CP; Department of Oral Maxillofacial-Head and Neck Oncology, Shanghai Ninth People's Hospital, Shanghai, China.
  • Yang X; Department of Oral Maxillofacial-Head and Neck Oncology, Shanghai Ninth People's Hospital, Shanghai, China.
  • Wang KJ; Department of Head and Neck Surgery, Zhejiang Cancer Hospital, Hangzhou, China.
  • Liu QJ; Department of Head and Neck Surgery, Gansu Province Cancer Hospital, Lanzhou, China.
  • Liu Y; Department of Head and Neck Surgery, National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
  • Wang Y; Department of Head and Neck Surgery, Fudan University Shanghai Cancer Center, Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China.
  • Lei BW; Department of Head and Neck Surgery, Fudan University Shanghai Cancer Center, Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China.
  • Yu PC; Department of Head and Neck Surgery, Fudan University Shanghai Cancer Center, Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China.
  • Hu JQ; Department of Head and Neck Surgery, Fudan University Shanghai Cancer Center, Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China.
  • Lu ZW; Department of Head and Neck Surgery, Fudan University Shanghai Cancer Center, Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China.
  • Hu WP; Department of Clinical Medicine, Shanghai Medical College, Fudan University, Shanghai, China.
  • Tian YX; Department of Head and Neck Surgery, Gansu Province Cancer Hospital, Lanzhou, China.
  • Wang YL; Department of Head and Neck Surgery, Fudan University Shanghai Cancer Center, Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China. Electronic address: wylheadneck@sina.com.
  • Ji QH; Department of Head and Neck Surgery, Fudan University Shanghai Cancer Center, Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China. Electronic address: jq_hai@126.com.
Eur J Surg Oncol ; 45(11): 2143-2150, 2019 Nov.
Article in En | MEDLINE | ID: mdl-31253544
ABSTRACT

BACKGROUND:

We aimed to explore whether the anatomic extent of lymph node metastases (AE-LNM) could independently predict prognosis of node-positive major salivary gland carcinoma (MaSGC).

METHODS:

A total of 376 pathologically node-positive MaSGC patients were identified from the Surveillance, Epidemiology and End Results database and constituted the training cohort. Using the X-Tile program, these patients were divided into three groups based on AE-LNM degrees. Discrimination of overall survival (OS) and disease-specific survival (DSS) was evaluated and compared with the 8th American Joint Committee on Cancer (AJCC) pN classification. The results were externally validated by 220 patients in a Chinese multicenter cohort (Validation cohort).

RESULTS:

Using the training cohort, AE-LNM was divided into Extent 1 (spread to parotid LNs or level I), Extent 2 (spread to level II-IV) and Extent 3 (spread to level V or bilateral LNs or rare LNs). Regarding both OS and DSS, the AE-LNM model revealed clear separation of survival curves, while the pN classification failed to discriminate the prognosis of pN1 and pN2 patients. When we incorporated both the AE-LNM model and AJCC pN classification into the same multivariate Cox analyses, AE-LNM was still an independent prognostic factor, while the AJCC pN classification lost its significance. These results were externally validated by the validation cohort.

CONCLUSION:

AE-LNM is an independent nodal prognosticator for node-positive MaSGC and may have improved discriminative ability over the current AJCC pN classification. Integration of anatomic extent of LNM into the current AJCC N classification could be considered.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Salivary Gland Neoplasms / Adenocarcinoma / Lymph Nodes Type of study: Clinical_trials / Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Aged / Female / Humans / Male / Middle aged Country/Region as subject: America do norte / Asia Language: En Journal: Eur J Surg Oncol Journal subject: NEOPLASIAS Year: 2019 Document type: Article Affiliation country:

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Salivary Gland Neoplasms / Adenocarcinoma / Lymph Nodes Type of study: Clinical_trials / Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Aged / Female / Humans / Male / Middle aged Country/Region as subject: America do norte / Asia Language: En Journal: Eur J Surg Oncol Journal subject: NEOPLASIAS Year: 2019 Document type: Article Affiliation country: